The forecasted liver malignant neoplasms mortality for males in the US shows a gradual increase from 2024 to 2028, with figures starting at 20.06 thousand deaths in 2024 and rising to 21.4 thousand by 2028. The recorded deaths in 2023 were 19.72 thousand. The year-on-year growth from 2023 to 2024 is approximately 1.72%. Over the last two years leading to 2024, the data reflects an increasing trend. The Compound Annual Growth Rate (CAGR) from 2024 to 2028 is around 1.37%.
Future trends to watch for include advances in medical technology and treatments that may influence survival rates. Additionally, factors like changes in risk factors (such as alcohol consumption and obesity rates) and early detection practices could impact these forecasts. Keeping an eye on policy changes and healthcare initiatives is crucial, as they will play a vital role in shaping the mortality trajectory for liver malignant neoplasms.
